{"ticker": "TPIV", "overview": {"cik": "1094038", "ticker": "MRKR", "name": "Marker Therapeutics, Inc.", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "10-Q", "date": "2026-05-15", "title": "Quarterly report", "accession": "0001104659-26-062763", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-04", "title": "FORM 8-K", "accession": "0001104659-26-054940", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-03-20", "title": "Form DEFA14A", "accession": "0001104659-26-032708", "price_sensitive": false}, {"form": "ARS", "date": "2026-03-20", "title": "Form ARS", "accession": "0001104659-26-032704", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-03-20", "title": "FORM DEF 14A", "accession": "0001104659-26-032694", "price_sensitive": false}, {"form": "8-K", "date": "2026-03-19", "title": "FORM 8-K", "accession": "0001104659-26-031309", "price_sensitive": true}, {"form": "10-K", "date": "2026-03-18", "title": "Annual report", "accession": "0001104659-26-031274", "price_sensitive": true}, {"form": "PRE 14A", "date": "2026-03-10", "title": "FORM PRE 14A", "accession": "0001104659-26-025917", "price_sensitive": false}, {"form": "8-K", "date": "2026-02-09", "title": "FORM 8-K", "accession": "0001104659-26-012063", "price_sensitive": true}, {"form": "4", "date": "2025-11-19", "title": "PRIMARY DOCUMENT", "accession": "0001768011-25-000003", "price_sensitive": false}, {"form": "4", "date": "2025-11-19", "title": "PRIMARY DOCUMENT", "accession": "0001270905-25-000003", "price_sensitive": false}, {"form": "4", "date": "2025-11-19", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-25-114081", "price_sensitive": false}, {"form": "SCHEDULE 13D/A", "date": "2025-11-17", "title": "Form SCHEDULE 13D/A", "accession": "0001072613-25-000858", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2025-11-14", "title": "Form SCHEDULE 13G/A", "accession": "0001172661-25-005191", "price_sensitive": false}, {"form": "8-K", "date": "2025-11-14", "title": "FORM 8-K", "accession": "0001104659-25-111940", "price_sensitive": true}, {"form": "10-Q", "date": "2025-11-13", "title": "Quarterly report", "accession": "0001104659-25-111502", "price_sensitive": true}, {"form": "8-K", "date": "2025-11-05", "title": "FORM 8-K", "accession": "0001104659-25-106669", "price_sensitive": true}, {"form": "4", "date": "2025-11-04", "title": "PRIMARY DOCUMENT", "accession": "0001884123-25-000010", "price_sensitive": false}, {"form": "4", "date": "2025-11-04", "title": "PRIMARY DOCUMENT", "accession": "0001755495-25-000003", "price_sensitive": false}, {"form": "3", "date": "2025-11-04", "title": "PRIMARY DOCUMENT", "accession": "0001884123-25-000009", "price_sensitive": false}, {"form": "8-K", "date": "2025-10-06", "title": "FORM 8-K", "accession": "0001104659-25-096935", "price_sensitive": true}, {"form": "8-K", "date": "2025-08-26", "title": "FORM 8-K", "accession": "0001104659-25-082783", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2025-08-20", "title": "Form SCHEDULE 13D/A", "accession": "0001104659-25-080957", "price_sensitive": false}, {"form": "SCHEDULE 13D/A", "date": "2025-08-19", "title": "Form SCHEDULE 13D/A", "accession": "0001104659-25-080213", "price_sensitive": false}, {"form": "SCHEDULE 13D/A", "date": "2025-08-18", "title": "Form SCHEDULE 13D/A", "accession": "0001072613-25-000647", "price_sensitive": false}]}, "description": "", "exchange": null, "stats": {"buy_n": 1, "buy_sum": 3120000.0, "sell_n": 1, "sell_sum": 19200.0, "net": 3100800.0, "insiders": 2, "first_date": "2011-03-23", "last_date": "2018-05-14"}, "metrics": {"ticker": "TPIV", "has_prices": false}, "trades": [{"id": "0001144204-18-054101", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Frederick Gerald Wasserman", "who_key": "Wasserman Frederick Gerald", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420418054101/0001144204-18-054101-index.htm", "trade_date": "2018-10-16", "timestamp": "2018-10-16", "mins": 4233042}, {"id": "0001144204-18-054103", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "David Laskow-Pooley", "who_key": "Laskow-Pooley David", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420418054103/0001144204-18-054103-index.htm", "trade_date": "2018-10-16", "timestamp": "2018-10-16", "mins": 4233042}, {"id": "0001144204-18-054105", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Mark Reddish", "who_key": "Reddish Mark", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420418054105/0001144204-18-054105-index.htm", "trade_date": "2018-10-16", "timestamp": "2018-10-16", "mins": 4233042}, {"id": "0001144204-18-054107", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Sherry Grisewood", "who_key": "Grisewood Sherry", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420418054107/0001144204-18-054107-index.htm", "trade_date": "2018-10-16", "timestamp": "2018-10-16", "mins": 4233042}, {"id": "0001144204-18-054109", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420418054109/0001144204-18-054109-index.htm", "trade_date": "2018-10-16", "timestamp": "2018-10-16", "mins": 4233042}, {"id": "0001144204-18-053247", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Glynn Wilson", "who_key": "WILSON GLYNN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420418053247/0001144204-18-053247-index.htm", "trade_date": "2018-10-09", "timestamp": "2018-10-09", "mins": 4243122}, {"id": "0001144204-18-050737", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Glynn Wilson", "who_key": "WILSON GLYNN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420418050737/0001144204-18-050737-index.htm", "trade_date": "2018-09-22", "timestamp": "2018-09-22", "mins": 4267602}, {"id": "0001408408-18-000007", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Eastern Capital Ltd", "who_key": "Eastern Capital LTD", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 3120000.0, "score": 59.3, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "A 10% owner backs up the truck on TPIV: $3.1M", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000140840818000007/0001408408-18-000007-index.htm", "trade_date": "2018-05-14", "timestamp": "2018-05-14", "mins": 4456242}, {"id": "0001144204-18-012627", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420418012627/0001144204-18-012627-index.htm", "trade_date": "2018-02-28", "timestamp": "2018-02-28", "mins": 4564242}, {"id": "0001144204-17-049443", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Peter L. Hoang", "who_key": "Hoang Peter L.", "role": "CEO and President, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 1018519.02, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420417049443/0001144204-17-049443-index.htm", "trade_date": "2017-09-22", "timestamp": "2017-09-22", "mins": 4793202}, {"id": "0001144204-17-049725", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Glynn Wilson", "who_key": "WILSON GLYNN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 404973.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420417049725/0001144204-17-049725-index.htm", "trade_date": "2017-09-22", "timestamp": "2017-09-22", "mins": 4793202}, {"id": "0001144204-17-045902", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Mark Reddish", "who_key": "Reddish Mark", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420417045902/0001144204-17-045902-index.htm", "trade_date": "2017-08-29", "timestamp": "2017-08-29", "mins": 4827762}, {"id": "0001144204-17-045903", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Sherry Grisewood", "who_key": "Grisewood Sherry", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420417045903/0001144204-17-045903-index.htm", "trade_date": "2017-08-29", "timestamp": "2017-08-29", "mins": 4827762}, {"id": "0001144204-17-045905", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "David Laskow-Pooley", "who_key": "Laskow-Pooley David", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420417045905/0001144204-17-045905-index.htm", "trade_date": "2017-08-29", "timestamp": "2017-08-29", "mins": 4827762}, {"id": "0001144204-17-045906", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Frederick Gerald Wasserman", "who_key": "Wasserman Frederick Gerald", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420417045906/0001144204-17-045906-index.htm", "trade_date": "2017-08-29", "timestamp": "2017-08-29", "mins": 4827762}, {"id": "0001144204-17-045909", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420417045909/0001144204-17-045909-index.htm", "trade_date": "2017-08-29", "timestamp": "2017-08-29", "mins": 4827762}, {"id": "0001144204-17-014231", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "John N. Bonfiglio", "who_key": "BONFIGLIO JOHN N", "role": "President and COO, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "President files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420417014231/0001144204-17-014231-index.htm", "trade_date": "2017-03-09", "timestamp": "2017-03-09", "mins": 5076882}, {"id": "0001144204-17-014235", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "Glynn Wilson", "who_key": "WILSON GLYNN", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420417014235/0001144204-17-014235-index.htm", "trade_date": "2017-03-09", "timestamp": "2017-03-09", "mins": 5076882}, {"id": "0001144204-16-139495", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "John N. Bonfiglio", "who_key": "BONFIGLIO JOHN N", "role": "President and COO, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 18125.579999999998, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "President files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420416139495/0001144204-16-139495-index.htm", "trade_date": "2016-12-12", "timestamp": "2016-12-12", "mins": 5202162}, {"id": "0001524858-16-000009", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000152485816000009/0001524858-16-000009-index.htm", "trade_date": "2016-11-28", "timestamp": "2016-11-28", "mins": 5222322}, {"id": "0000899243-16-028032", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "Michael Loiacono", "who_key": "Loiacono Michael", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000089924316028032/0000899243-16-028032-index.htm", "trade_date": "2016-08-25", "timestamp": "2016-08-25", "mins": 5359122}, {"id": "0001408408-16-000084", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "Eastern Capital Ltd", "who_key": "Eastern Capital LTD", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "NON-SIGNAL", "amount": 2500000.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "10% owner files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000140840816000084/0001408408-16-000084-index.htm", "trade_date": "2016-08-10", "timestamp": "2016-08-10", "mins": 5380722}, {"id": "0000899243-16-025288", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "John N. Bonfiglio", "who_key": "BONFIGLIO JOHN N", "role": "See Remarks, Director", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000089924316025288/0000899243-16-025288-index.htm", "trade_date": "2016-07-15", "timestamp": "2016-07-15", "mins": 5418162}, {"id": "0000899243-16-012297", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "Frederick Gerald Wasserman", "who_key": "Wasserman Frederick Gerald", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000089924316012297/0000899243-16-012297-index.htm", "trade_date": "2016-01-26", "timestamp": "2016-01-26", "mins": 5664402}, {"id": "0000899243-15-008209", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "Sherry Grisewood", "who_key": "Grisewood Sherry", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000089924315008209/0000899243-15-008209-index.htm", "trade_date": "2015-11-12", "timestamp": "2015-11-12", "mins": 5772402}, {"id": "0000899243-15-008210", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "Glynn Wilson", "who_key": "WILSON GLYNN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 243078.11, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000089924315008210/0000899243-15-008210-index.htm", "trade_date": "2015-11-12", "timestamp": "2015-11-12", "mins": 5772402}, {"id": "0000899243-15-008211", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "Mark Reddish", "who_key": "Reddish Mark", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000089924315008211/0000899243-15-008211-index.htm", "trade_date": "2015-11-12", "timestamp": "2015-11-12", "mins": 5772402}, {"id": "0001408408-15-000046", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "Eastern Capital Ltd", "who_key": "Eastern Capital LTD", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "NON-SIGNAL", "amount": 2000000.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "10% owner files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000140840815000046/0001408408-15-000046-index.htm", "trade_date": "2015-09-09", "timestamp": "2015-09-09", "mins": 5864562}, {"id": "0000899243-15-007780", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "John N. Bonfiglio", "who_key": "BONFIGLIO JOHN N", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000089924315007780/0000899243-15-007780-index.htm", "trade_date": "2015-07-23", "timestamp": "2015-07-23", "mins": 5933682}, {"id": "0001408408-15-000038", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC", "who": "Eastern Capital Ltd", "who_key": "Eastern Capital LTD", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "NON-SIGNAL", "amount": 2500000.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "10% owner files routine paperwork on TPIV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000140840815000038/0001408408-15-000038-index.htm", "trade_date": "2015-06-16", "timestamp": "2015-06-16", "mins": 5986962}], "recent_buys": [{"id": "0001408408-18-000007", "src": "INSIDERS", "ticker": "TPIV", "cik": "1094038", "company": "Marker Therapeutics, Inc.", "company_raw": "TAPIMMUNE INC.", "who": "Eastern Capital Ltd", "who_key": "Eastern Capital LTD", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 3120000.0, "score": 59.3, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "A 10% owner backs up the truck on TPIV: $3.1M", "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000140840818000007/0001408408-18-000007-index.htm", "trade_date": "2018-05-14", "timestamp": "2018-05-14", "mins": 4456242}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Eastern Capital Ltd", "who_key": "Eastern Capital LTD", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 3120000.0, "sold": 0, "net": 3120000.0, "trades": 1, "top_score": 59.3, "lean": "buying", "history": [{"action": "BUY", "amount": 3120000.0, "date": "2018-05-14", "score": 59.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000140840818000007/0001408408-18-000007-index.htm"}], "latest": {"action": "BUY", "amount": 3120000.0, "date": "2018-05-14", "score": 59.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000140840818000007/0001408408-18-000007-index.htm"}}, {"who": "Denis Corin", "who_key": "CORIN DENIS", "role": "President and CFO, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 0, "sold": 19200.0, "net": -19200.0, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 19200.0, "date": "2011-03-23", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420411020269/0001144204-11-020269-index.htm"}], "latest": {"action": "SELL", "amount": 19200.0, "date": "2011-03-23", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1094038/000114420411020269/0001144204-11-020269-index.htm"}}], "activity": [], "announcements": [{"form": "10-Q", "date": "2026-05-15", "title": "Quarterly report", "accession": "0001104659-26-062763", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-04", "title": "FORM 8-K", "accession": "0001104659-26-054940", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-03-20", "title": "Form DEFA14A", "accession": "0001104659-26-032708", "price_sensitive": false}, {"form": "ARS", "date": "2026-03-20", "title": "Form ARS", "accession": "0001104659-26-032704", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-03-20", "title": "FORM DEF 14A", "accession": "0001104659-26-032694", "price_sensitive": false}, {"form": "8-K", "date": "2026-03-19", "title": "FORM 8-K", "accession": "0001104659-26-031309", "price_sensitive": true}, {"form": "10-K", "date": "2026-03-18", "title": "Annual report", "accession": "0001104659-26-031274", "price_sensitive": true}, {"form": "PRE 14A", "date": "2026-03-10", "title": "FORM PRE 14A", "accession": "0001104659-26-025917", "price_sensitive": false}, {"form": "8-K", "date": "2026-02-09", "title": "FORM 8-K", "accession": "0001104659-26-012063", "price_sensitive": true}, {"form": "4", "date": "2025-11-19", "title": "PRIMARY DOCUMENT", "accession": "0001768011-25-000003", "price_sensitive": false}, {"form": "4", "date": "2025-11-19", "title": "PRIMARY DOCUMENT", "accession": "0001270905-25-000003", "price_sensitive": false}, {"form": "4", "date": "2025-11-19", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-25-114081", "price_sensitive": false}, {"form": "SCHEDULE 13D/A", "date": "2025-11-17", "title": "Form SCHEDULE 13D/A", "accession": "0001072613-25-000858", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2025-11-14", "title": "Form SCHEDULE 13G/A", "accession": "0001172661-25-005191", "price_sensitive": false}, {"form": "8-K", "date": "2025-11-14", "title": "FORM 8-K", "accession": "0001104659-25-111940", "price_sensitive": true}, {"form": "10-Q", "date": "2025-11-13", "title": "Quarterly report", "accession": "0001104659-25-111502", "price_sensitive": true}, {"form": "8-K", "date": "2025-11-05", "title": "FORM 8-K", "accession": "0001104659-25-106669", "price_sensitive": true}, {"form": "4", "date": "2025-11-04", "title": "PRIMARY DOCUMENT", "accession": "0001884123-25-000010", "price_sensitive": false}, {"form": "4", "date": "2025-11-04", "title": "PRIMARY DOCUMENT", "accession": "0001755495-25-000003", "price_sensitive": false}, {"form": "3", "date": "2025-11-04", "title": "PRIMARY DOCUMENT", "accession": "0001884123-25-000009", "price_sensitive": false}, {"form": "8-K", "date": "2025-10-06", "title": "FORM 8-K", "accession": "0001104659-25-096935", "price_sensitive": true}, {"form": "8-K", "date": "2025-08-26", "title": "FORM 8-K", "accession": "0001104659-25-082783", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2025-08-20", "title": "Form SCHEDULE 13D/A", "accession": "0001104659-25-080957", "price_sensitive": false}, {"form": "SCHEDULE 13D/A", "date": "2025-08-19", "title": "Form SCHEDULE 13D/A", "accession": "0001104659-25-080213", "price_sensitive": false}, {"form": "SCHEDULE 13D/A", "date": "2025-08-18", "title": "Form SCHEDULE 13D/A", "accession": "0001072613-25-000647", "price_sensitive": false}], "performance": {"ticker": "TPIV", "has_prices": false, "summary": null, "buys": [{"who": "Eastern Capital LTD", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 3120000.0, "date": "2018-05-14", "score": 59.3, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}